These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 26394702)

  • 1. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
    Jankowska AM; Millward CL; Caldwell CW
    Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic biomarkers.
    Chan TA; Baylin SB
    Curr Top Microbiol Immunol; 2012; 355():189-216. PubMed ID: 21818705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic epigenetic biomarkers in cancer.
    Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
    Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer epigenetics: Moving forward.
    Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
    PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic alterations in cancer and personalized cancer treatment.
    Miozzo M; Vaira V; Sirchia SM
    Future Oncol; 2015; 11(2):333-48. PubMed ID: 25591842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
    Singh AK; Chandra N; Bapat SA
    Clin Cancer Res; 2015 Nov; 21(22):5151-63. PubMed ID: 26130461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers.
    Olkhov-Mitsel E; Bapat B
    Cancer Med; 2012 Oct; 1(2):237-60. PubMed ID: 23342273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic profiling joins personalized cancer medicine.
    Heyn H; Méndez-González J; Esteller M
    Expert Rev Mol Diagn; 2013 Jun; 13(5):473-9. PubMed ID: 23782254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics and oncology.
    Mummaneni P; Shord SS
    Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and cancer.
    Kanwal R; Gupta S
    J Appl Physiol (1985); 2010 Aug; 109(2):598-605. PubMed ID: 20203073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
    Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the epigenetic code of cancer for therapy.
    Smith LT; Otterson GA; Plass C
    Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation patterns in cancer: a clinical view.
    Paska AV; Hudler P
    Biochem Med (Zagreb); 2015; 25(2):161-76. PubMed ID: 26110029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.